The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2015 OMIG Meeting Agenda

Ocular Microbiology and Immunology Group
49th Annual Meeting
Friday, November 13, 2015
Caesars Palace

Irmgard Behlau, MD and Anat Galor, MD

Click on titles to view abstracts
6:45 a.m. Registration
7:30 a.m. Introduction by Moderators
7:35 a.m.

2014 Harry Hirsch Leiter Award Recipient: R.A. Eiferman
Put The Preservative In The Bottle, Not In The Eye!

7:43 a.m.

1. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity
Kimberly D. Tran, MD

7:50 a.m.

2. Development of Herpes Zoster Ophthalmicus after Herpes Zoster Vaccination
Shruti Aggarwal, MD

7:57 a.m. 3. Effect of Corneal Scar Location in Patients with Herpes Simplex Keratitis on Bilateral Corneal Nerve Alteration: An In Vivo Confocal Microscopy Study
Chareenun Chirapapaisan, MD
8:04 a.m.

4. Is Benzalkonium Chloride (BAK) Effective against Adenovirus?
Eric Romanowski

8:11 a.m. 5. Epstein-Barr Virus-Associated Scleritis Responsive to Valganciclovir: A Case Report
Robert Garoon, MD
8:18 a.m. 6. Staphylococcus Caprae Polymicrobial Keratitis
David J. Harris, III, MD
8:25 a.m. 7. Molecular Epidemiology of Ocular Staphylococcus aureus Infections
Paulo J. M. Bispo, PhD
8:32 a.m. 8. Staphylococcus aureus Keratitis: Multi-Locus Sequence Typing and Genome Sequencing to Identify Lineage, Virulence and Antibiotic Resistance Genes
Irmgard Behlau, MD
8:39 a.m. 9. Microbial Keratitis at an Urban Public Hospital: A 10-year update
David T. Truong, MD
8:46 a.m. 10. Ocular Pathogens and Antibiotic Sensitivity of Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, Saudi Arabia - 2011-2014
Donald U. Stone, MD
8:53 a.m. 11. Organ culture model for microbial keratitis in ex vivo rabbit and human corneas
Prashant Garg, MD
9:00 a.m. 12. Corneal Endothelial Safety in Far Ultraviolet Light (222 nm) Antimicrobial Ophthalmic Care
J. James Rowsey, MD
9:07 a.m. 13. Photodynamic Therapy-Potential as Alternative/Adjunctive Therapy for MRSA Keratitis?
Darlene Miller, DHSc,MPH,CIC
9:14 a.m. 14. Intracameral Cross-Linked Hyaluronic Acid Plus Vancomycin—Sustained Release and the First Step Towards Effective Dropless Eye Surgery
Richard A. Eiferman, MD
9:21 a.m BREAK
9:36 a.m. 15. Diffusion of Moxifloxacin across Corneal Collagen Shields
Kimberly Brothers, PhD
9:43 a.m. 16. The Role of Scleral Debridement in Infectious Scleritis
Laura A. Vickers, MD
9:50 a.m. 17. Changing Azole Susceptibility in the Mycotic Ulcer Treatment Trial I
N. Venkatesh Prajna, MD
9:57 a.m. 18. The effect of light exposure on the efficacy and safety of Amphotericin B in
Optisol-GS corneal storage media

Katherine Duncan
10:04 a.m. 19. Fungal endophthalmitis after Descemet Stripping Automated Endothelial Keratoplasty due to endogenously infected grafts from the same donor
Sotiria Palioura, MD
10:11 a.m. 20. Candida interface infections among a cluster of positive fungal corneoscleral rim cultures used in Descemet's stripping automated endothelial keratoplasty
Edmund Tsui, MD
10:18 a.m. 21. Fungal Keratitis and Endophthalmitis after using Gamma-Irradiated Corneas as Carriers for Boston Type I Keratoprosthesis
Mansi D. Talati, MD
10:25 a.m. 22. Hypochlorous Acid: A Candidate Prophylactic Antifungal Agent for Boston
Keratoprosthesis Patients

Silvia Odorcic, MD
10:32 a.m. 23. Initiation of systemic anti-neoplastic agents contributing to corneal transplant rejection?
A case series

Ashley Rohr, MD
10:39 a.m. 24. Pure 0.01% Hypochlorous Acid Cleanser without Sodium Hypochlorite Impurities for Treating Demodex Blepharitis
Kathryn Najafi-Tagol, MD
10:46 a.m.

25. Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metallopeptidase 9 Point of Care Test versus Negative Patients
Victoria S. Chang, MD

10:53 a.m. 26. Features of neuropathic ocular pain in dry eye are associated with chronic comorbid pain syndromes (CPS)
Hatim Batawi, MD
11:00 a.m. 27. Low-dose topical preservative-free Dexamethasone 0.01% and 0.05% for treatment of chronic ocular surface disease unresponsive to commercially available steroids, antibiotics, and
anti-allergy agents

Adnan Mallick, MD
11:07 a.m. 28. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated with Ocular GVHD
Ahmad Kheirkhah, MD
11:20 a.m. Thygeson Lecture: New Insights Into the Pathogenesis of Fungal Keratitis
Eric Pearlman, PhD
Department of Ophthalmology and Department of Physiology and Biophysics
Director, Institute for Immunology University of California, Irvine
12:05 p.m. Closing Comments and Awards
12:15 p.m.

Business Luncheon - Genoa Room

Top of Page